Psychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.
How can digital therapeutics overcome barriers to psychiatric treatment in forensic settings?
The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Session at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.
Evidence indicates that children and adolescents with ADHD have a more than 4-fold increased risk of schizophrenia spectrum and other psychotic disorders in adulthood compared with the general population.
Care partners for patients with schizophrenia can greatly benefit from psychoeducation provided by clinicians.
Women should be provided with multiple options for treatment if they decide to engage in mental health care during this critical period.
The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.
Joining together to discuss psychosis, 3 British experts discuss various ways to respond to and help people who have experienced both trauma and psychosis.
Thanks to a recent Sigourney Award, this association is achieving well-deserved recognition.
AI chatbots pose significant mental health risks, often exacerbating issues like suicide, self-harm, and delusions, highlighting urgent regulatory needs.
Want to stay in the loop on the latest novel neuroplastogen for major depressive disorder, DLX-001? Check out this update.
Perinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Yale's groundbreaking research aims to revolutionize autism treatment through advanced brain modeling and noninvasive communication methods, enhancing patient outcomes.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Panelists discuss how a patient named Kerstin was diagnosed with attention-deficity/hyperactivity disorder (ADHD) later in life during college when she struggled with organization and scheduling beyond her known dyslexia, leading to successful treatment with various stimulant medications including participation in clinical trials.
Postpartum psychosis has a complicated presentation and is often misdiagnosed or missed in patients.
Explore the intricate relationship between sleep disorders and psychiatric conditions, diagnostic challenges, and effective management strategies, in this Special Report article.
There is no accurate profile of who will become a school shooter, so mental health clinicians should react as they would with any patient threatening violence: inquire, gain collateral data, assess, and respond.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
This article was developed and sponsored in collaboration with Neurocrine Biosciences, Inc. Amy LaCouture, RN, BSN, PMHNP-BC and Linda Trinh, DNP, MPH, FNP-C, PMHNP-BC have been compensated by Neurocrine Biosciences, Inc. to author this article and share their perspectives.
During National Men’s Health Month, take time to consider the unique mental health needs of male patients.
In this journal club, a medical student and an addiction psychiatrist review a thematic analysis of successful prevention efforts in states with declining rates of opioid-related overdose deaths.
Perinatal mood and anxiety disorders affect 1 in 5 of perinatal individuals who are pregnant or up to 1 year postpartum. Over the past 2 decades, the US has seen an alarming rise in these disorders.
Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.
In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.
"Cumulatively, the findings of such reports have led to a concerted effort to encourage physicians to monitor patients for manic symptoms on initiation, reintroduction, and dose modulation of corticosteroid therapy."